**Laboratory Medicine resident's approval is required for hospital inpatients and patients in Emergency Department.**
Prothrombin (factor II) is one of the blood coagulation factors. A variant (commonly known as nucleotide 20210G>A; G20210A; NM_000506.4:c.*97G>A) in the 3' untranslated region of the prothrombin gene (F2) is associated with an increased risk for venous thrombosis. Approximately 20% of Dutch patients with a family history of venous thrombosis are heterozygotes for the 20210A allele, as compared to about 1% of healthy controls. In a population-based study, the 20210A allele appears to increase the risk of venous thrombosis about threefold for adults of both sexes. This test determines the presence or absence of the 20210G (normal) and 20210A (variant) alleles in the prothrombin gene.
Indications for testing include:
Code | Name |
---|---|
PDRSLT | Prothrombin DNA Result |
PDINT | Prothrombin DNA Interpretation |
PDMETH | Prothrombin DNA Method |
PDDI | Prothrombin DNA Director |
Next-generation sequencing is performed to detect the variant F2 allele. In Human Genome Variation Society nomenclature, this variant is officially designated as NM_000506.4:c.*97G>A. This test was developed and its performance characteristics determined by the Department of Laboratory Medicine at the University of Washington.
No variant nucleotide 20210A (NM_000506.4:c.*97G>A) detected.
BLOOD:
SALIVA:
Contact laboratory for validated collection kit.
Refrigerate whole blood up to 1 week
Outside Laboratory: Ship whole blood at ambient temperature to arrive within 1 week of specimen collection
**Laboratory Medicine resident's approval is required for hospital inpatients and patients in Emergency Department.** Approval is NOT required for hospital outpatients, clinic patients or outside clients.
UW-MT |
Genetics
Attention: Genetics Lab Tel: 206-598–6429 M–F (7:30 AM–4:00 PM) Tel (EXOME only): 206-543-0459 |
Faculty |
---|
For pricing information, contact Client Support Services 206-520-4600 or 800-713-5198.